Study design: Retrospective single centre study. Objectives: To evaluate a low-dose radioisotope imaging procedure for assessment of implanted intrathecal drug delivery and to compare the radiation ...
Onasemnogene abeparvovec-brve is the first gene replacement therapy approved for SMA patients aged 2 years and older, expanding access beyond infants. Phase 3 trials demonstrated significant motor ...
Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). May be stored in a contrast media warmer for up to one month, not to exceed 37°C (98.6°F). Intrathecal ...
Here are four ambulatory surgery centers that offer unique procedures pain management. If you would like to recommend another surgery center for this list, contact Anuja Vaidya at ...
Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). May be stored in a contrast media warmer for up to one month, not to exceed 37°C (98.6°F). IV administration: ...
Treatment of CNS involvement entails intrathecal cytarabine and/or methotrexate until CSF cytology is clear of malignant cells. Liposomal extended-release cytarabine (DepoCyte®) has been investigated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback